Yoshinaga, Masahiro <br/><br/>
15-LOX-1 inhibits p21 (Cip/WAF 1) expression by enhancing MEK-ERK 1/2 signaling in colon carcinoma cells.  [electronic resource] 

 -  Prostaglandins & other lipid mediators  Jan 2004 
 - 111-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1098-8823 
<br/><br/><label>Standard No.: </label>10.1016/j.prostaglandins.2004.01.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Arachidonate 15-Lipoxygenase--metabolism<br/>Butyrates--pharmacokinetics<br/>Caco-2 Cells<br/>Carcinoma--metabolism<br/>Cell Cycle Proteins--metabolism<br/>Colonic Neoplasms--metabolism<br/>Cyclin-Dependent Kinase Inhibitor p21<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>HCT116 Cells<br/>Humans<br/>Leukotrienes--metabolism<br/>Lipid Peroxides--metabolism<br/>Lipoxygenase Inhibitors--pharmacology<br/>Masoprocol--pharmacology<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3--metabolism<br/>Phosphorylation--drug effects<br/>Signal Transduction--drug effects<br/>Stearic Acids--pharmacology